Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
Sun S, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A Jr, Teshome M, Black D, Hwang RF, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM.
Sun S, et al. Among authors: van la parra rfd.
Ann Surg Oncol. 2019 Oct;26(10):3071-3079. doi: 10.1245/s10434-019-07533-2. Epub 2019 Jul 24.
Ann Surg Oncol. 2019.
PMID: 31342361